Severe Acute Respiratory Syndrome Coronavirus 2
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), also known as 2019-nCoV (2019 Novel Coronavirus), is a virus that can cause serious illnesses from the common cold. SARS-CoV-2 Spike protein consists of S1 domain and S2 domain. S1 contains a receptor binding domain (RBD) that specifically binds to the receptor angiotensin converting enzyme 2 (ACE2) on target cells. It is believed that the SARS-CoV-2 spike protein (RBD) has potential value for the diagnosis of the virus.
Human Anti-SARS-CoV-2(2019-nCoV) RBD Antibody (CAT#: MO-NAB-00873W)
-
- Host species: Human
- Species Reactivity: SARS-CoV-2; SARS-COV
- Application: WB, ELISA
- Size: 100µL
- Conjugate: NONE
- Alternative Names: Spike glycoprotein, 2019-nCov RBD Protein, 2019-nCoV Spike RBD Protein
Human Anti-SARS-CoV-2(2019-nCoV) RBD Antibody (CAT#: MO-NAB-00888W)
-
- Host species: Human
- Species Reactivity: SARS-CoV-2; SARS-COV
- Application: WB, ELISA
- Conjugate: NONE
- Alternative Names: Spike glycoprotein, 2019-nCov RBD Protein, 2019-nCoV Spike RBD Protein
Human Anti-SARS-CoV-2(2019-nCoV) RBD Antibody (CAT#: MO-NAB-00889W)
-
- Host species: Human
- Species Reactivity: SARS-CoV-2; SARS-COV
- Application: WB, ELISA
- Conjugate: NONE
- Alternative Names: Anti Spike glycoprotein antibody, Anti 2019-nCoV RBD antibody, Anti 2019-nCoV Spike RBD antibody
Human Anti-SARS-CoV-2(2019-nCoV) RBD Antibody (CAT#: MO-NAB-00907W)
-
- Host species: Human
- Species Reactivity: SARS-CoV-2; SARS-COV
- Application: WB, ELISA
- Conjugate: NONE
- Alternative Names: Anti Spike glycoprotein antibody, Anti 2019-nCoV RBD antibody, Anti 2019-nCoV Spike RBD antibody
Anti-SARS-CoV-2(2019-nCoV) RBD Antibody (CAT#: MO-NAB-00909W)
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV), SARS-CoV-2; SARS-COV
- Application: ELISA, Neut
- Protein: Spike glycoprotein
- Conjugate: NONE
- Alternative Names: Anti Spike glycoprotein antibody, Anti 2019-nCoV RBD antibody, Anti 2019-nCoV Spike RBD antibody
For Research Use Only | Not For Clinical Use.